GlassScriptPhysician profile
Tracie E Fullove
NPI 1962865659
$1,528.75
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $118 · 2021: $26.23 · 2022: $340 · 2023: $383 · 2024: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $738.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $253.26 | 2019-2024 | Rybelsus, Ozempic |
| Vanda Pharmaceuticals INC. | $219.58 | 2020-2024 | Hetlioz, Fanapt |
| Abbvie INC. | $159.82 | 2022-2024 | |
| Amgen INC. | $124.99 | 2019 | |
| Abbott Laboratories | $122.63 | 2019-2024 | Freestyle Libre 2 |
| Neurocrine Biosciences, INC. | $113.70 | 2023-2024 | Ingrezza |
| Gilead Sciences, INC. | $64.66 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $62.73 | 2020-2024 | Flumist Quadrivalent, Farxiga |
| Baxter Healthcare | $62.57 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Horizon Therapeutics Plc | $61.96 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.04 | 2021-2024 | Trulance, Xifaxan |
| Lilly USA, LLC | $46.33 | 2023-2024 | Mounjaro |
| Organon LLC | $42.92 | 2022-2023 | Nexplanon |
| Teva Pharmaceuticals USA, INC. | $41.28 | 2023 | Austedo Xr |
| Glaxosmithkline, LLC. | $28.87 | 2020-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $25.14 | 2023 | Azstarys |
| Xeris Pharmaceuticals, INC. | $17.61 | 2022 | |
| Dexcom, INC. | $16.97 | 2023 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $13.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracie Fullove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.